Previous studies showed that overexpression of GSDMB promoted aggressiveness of breast cancer with poor prognosis, and inhibiting GSDMB expression enhanced the cancer sensitivity to trastuzumab and limited cancer cell invasion in vitro36–38. The gene discussed is GSDMB; the disease is breast carcinoma.